VA5
Modify Date: 2024-02-18 16:34:45
VA5 structure
|
Common Name | VA5 | ||
|---|---|---|---|---|
| CAS Number | 2088001-24-3 | Molecular Weight | 590.624 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 955.8±65.0 °C at 760 mmHg | |
| Molecular Formula | C31H34N4O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 531.8±34.3 °C | |
Use of VA5VA5 is a BTK kinaseinhibitor. VA5 has the potential to be used to study diseases associated with BTK kinase activity. |
| Name | Benzyl [(2S)-6-(acryloylamino)-1-{4-[(7-hydroxy-2-oxo-2H-chromen-3-yl)carbonyl]-1-piperazinyl}-1-oxo-2-hexanyl]carbamate |
|---|---|
| Synonym | More Synonyms |
| Description | VA5 is a BTK kinaseinhibitor. VA5 has the potential to be used to study diseases associated with BTK kinase activity. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 955.8±65.0 °C at 760 mmHg |
| Molecular Formula | C31H34N4O8 |
| Molecular Weight | 590.624 |
| Flash Point | 531.8±34.3 °C |
| Exact Mass | 590.237671 |
| LogP | 1.80 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.610 |
| Carbamic acid, N-[(1S)-1-[[4-[(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)carbonyl]-1-piperazinyl]carbonyl]-5-[(1-oxo-2-propen-1-yl)amino]pentyl]-, phenylmethyl ester |
| Benzyl [(2S)-6-(acryloylamino)-1-{4-[(7-hydroxy-2-oxo-2H-chromen-3-yl)carbonyl]-1-piperazinyl}-1-oxo-2-hexanyl]carbamate |
| VA5 |